Burrill Conferences


PlatinumPresented withGold SponsorSilverBronzeEvent Partners

Life Sciences Conferences

The Burrill India Life Sciences Meeting


Preliminary Agenda

June 16, 2008

7:30 a.m. – 8:00 a.m.  

Breakfast & Registration


8:00 a.m. – 8:45 a.m.  

Keynote Presentation: 

Biotech State of the Industry – A Global Look

G. Steven Burrill, CEO, Burrill & Company


8:45 a.m. – 9:00 a.m.  

China / San Diego / California - Global Biotech Cluster 

Joe Panetta, President & CEO, BIOCOM


9:00 a.m. -9:15 a.m 



9:15 a.m. – 10:30 a.m.

The Life Science Revolution in India

      Areas of Innovation that India is Globally Competitive in Today

       - Rashmi Barbhaiya, PhD, CEO & Managing Director, Advinus Therapeutics

       - Ajit Singh, PhD, CEO, Siemens Healthcare, Image & Knowledge 

         Management Group

   •   Reaching Beyond: From Domestic to International Markets

       - Arun Chandavarkar, PhD, COO, Biocon

       - Greg Wiederrecht, PhD, VP External Scientific Affairs, Merck

   •   Creating Value in a Global Marketplace

       - Sreeni Devidas, PhD VP, Business Development, GVK BioSciences

       - Dr. Swati Piramal, Director, Strategic Alliances & Communications, Nicholas  

         Piramal India Ltd


Moderated by: Tania Fernandez, PhD, Director India, Burrill & Comapny

10:30 a.m – 11:45 a.m.          

Models of Global Growth by Leading Indian Companies

   •   Expansion into US Specialty Therapeutics

       - Jeffrey Wasserstein, EVP, North America Specialty, Dr. Reddy’s  


   •   Leadership in Global Generics through Regional Expansion

        - Shyam Bishen, PhD, VP, Corporate Development, Ranbaxy Pharmaceuticals

   •   Transitioning from Services to Proprietary Drug Development

        - Venkat Jasti, Vice Chairman & CEO, Suven Life Sciences

   •   Vertical Integration Via M&A

        - Sridhar Mosur, President & CEO, Jubilant Discovery Services &

          Jubilant Biosys   

   •   Growth Through Strategic Partnerships

       - Andres Liivak, Partner, Reed Smith


Moderated by: Mohan Iyer, Managing Director, Merchant Banking Group, Burrill

                        & Company   


11:45 a.m. – 12:45 p.m.

Networking Lunch


12:45 p.m. – 2:00 p.m.           

Capital Markets in India

   •   Where is the Capital Coming From?

        -  Anna Lavelle, PhD, CEO & Executive Director, AusBiotech 

        - Robert Power, VP, Investment Banking, NYSE  Euronext 

        - Villoo Morawalla Pate, PhD, Founder and Managing Director of Avestha

         Gengraine Technologies

   •   How Can You Build Value in Indian Life Science Companies?

 - Dr. Anula Jayasuriya, PhD, Managing Director, Evolvence India Life Science


        -Yatin Mundkur, Partner, Artiman Ventures  

Moderated by: Roger Wyse, PhD, Managing Director, Burrill & Company

2:00 p.m. – 2:45 p.m.      

Shining examples of Indian life science companies on the horizon

  • Advinus (Pharma): Kasim Mookhtiar, PhD, CSO & SVP
  • Chembiotek- A TCG Lifesciences Co. (Discovery Services): Ashis Saha, PhD, VP, Discovery
  • MetaHelix Life Sciences (Agbio): Dr. Vasudera Rao, President, Agriculture Technologies          
  • Ocimum Biosolutions (Services): Anuradha Acharya, CEO

Moderated by: Ganesh Kishore, PhD, Managing Director, Burrill & Company  


2:45 p.m. – 3:00 p.m.             



3:00 p.m. – 3:45 p.m. 

Year 2020 – China/India: A Comparison      

   •   Futurist who can find what India will look like in 2020:

        Rashmi Barbhaiya, PhD, CEO & Managing Director, Advinus Therapeutics

   •   Futurist who can find what China will look like in 2020:

       Hongguang Wang,PhD, Director General, China National Center for       


Moderated by: G. Steven Burrill, CEO, Burrill & Company


3:45 p.m. – 4:00 p.m. 

Closing Remarks

G. Steven Burrill, CEO, Burrill & Company


4:00 p.m. – 5:30 p.m. 

Networking Reception

Sponsored by:  Wilson Sonsini Goodrich & Rosati